MARKET

CLVLF

CLVLF

Clinuvel Pharma
OTCPK
8.34
NaN%
Closed 09:30 02/20 EST
OPEN
--
PREV CLOSE
8.34
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
8.34
52 WEEK LOW
6.90
MARKET CAP
418.67M
P/E (TTM)
17.68
1D
5D
1M
3M
1Y
5Y
1D
Clinuvel Flags Wide-Ranging Risks Ahead of Institutional Investor Meetings
TipRanks · 02/01 22:28
Clinuvel Starts Preclinical Dosing of New Controlled-Release Peptide Platform VLRX-L
TipRanks · 01/11 22:37
Clinuvel Reports New Positive Vitiligo Data for SCENESSE® in Darker-Skinned Patients
TipRanks · 01/07 23:17
Clinuvel Pharmaceuticals Reports Lapse of 5,425 Performance Rights
TipRanks · 01/01 23:27
Clinuvel Files U.S. GAAP 20-F as It Targets Nasdaq ADR Uplisting
TipRanks · 12/18/2025 22:54
CLINUVEL Expands Singapore RD&I Centre for Advanced Peptide Therapies
TipRanks · 12/07/2025 22:47
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies
Barchart · 12/07/2025 20:37
CLINUVEL Targets Mid-2026 for European Filing of NEURACTHEL® Instant
TipRanks · 12/02/2025 01:38
More
About CLVLF
Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Webull offers Clinuvel Pharmaceuticals Ltd stock information, including OTCPK: CLVLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLVLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLVLF stock methods without spending real money on the virtual paper trading platform.